From the Guidelines
Foquest, which is not directly mentioned in the provided evidence, is assumed to be related to the context of osteoporosis management, and its side effects are likely similar to those of bisphosphonates, including mild-to-moderate flu-like symptoms, esophagitis, dysphagia, and gastric ulcers. The side effects of bisphosphonates, which may be relevant to Foquest, can vary depending on the route of administration, with IV administration associated with flu-like symptoms, such as myalgias, arthralgias, fevers, and headaches, within the first 3 days after therapy, which generally resolve within 3 to 4 days, but may persist for up to 14 days after initial infusions 1.
- Common side effects of bisphosphonates, potentially related to Foquest, include:
- Mild-to-moderate flu-like symptoms
- Esophagitis
- Dysphagia
- Gastric ulcers
- Less common but more serious side effects, potentially related to Foquest, include:
- Medication-related osteonecrosis of the jaw (MRONJ)
- Bone pain
- Atrial fibrillation
- Esophageal cancer
- Atypical femoral fractures The incidence of these serious side effects is rare, with atypical femoral fractures reported to range from 3.0 to 9.8 cases per 100,000 patient-years, and the incidence of MRONJ associated with bisphosphonate use for osteoporosis ranging from less than one to 28 cases per 100,000 person-years of treatment 1.
From the Research
Side Effects of Foquest
There are no research papers to assist in answering this question, as none of the provided studies mention Foquest.
Available Information on Other Medications
- The studies provided discuss various medications, including nivolumab, chemotherapy, and docetaxel, but do not mention Foquest 2, 3, 4, 5, 6.
- These studies focus on topics such as cancer treatment, polypharmacy, and medication risk management, but do not provide information on Foquest.
- The side effects of medications like nivolumab and chemotherapy are discussed in some of the studies, but Foquest is not mentioned 2, 5.